Your browser doesn't support javascript.
loading
Characterisation and prion transmission study in mice with genetic reduction of sporadic Creutzfeldt-Jakob disease risk gene Stx6.
Jones, Emma; Hill, Elizabeth; Linehan, Jacqueline; Nazari, Tamsin; Caulder, Adam; Codner, Gemma F; Hutchison, Marie; Mackenzie, Matthew; Farmer, Michael; Coysh, Thomas; De Oliveira, Michael Wiggins; Al-Doujaily, Huda; Sandberg, Malin; Viré, Emmanuelle; Cunningham, Thomas J; Asante, Emmanuel A; Brandner, Sebastian; Collinge, John; Mead, Simon.
Afiliação
  • Jones E; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Hill E; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Linehan J; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Nazari T; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Caulder A; Mary Lyon Centre at MRC Harwell, Harwell Campus, Oxfordshire OX11 0RD, UK.
  • Codner GF; Mary Lyon Centre at MRC Harwell, Harwell Campus, Oxfordshire OX11 0RD, UK.
  • Hutchison M; Mary Lyon Centre at MRC Harwell, Harwell Campus, Oxfordshire OX11 0RD, UK.
  • Mackenzie M; Mary Lyon Centre at MRC Harwell, Harwell Campus, Oxfordshire OX11 0RD, UK.
  • Farmer M; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Coysh T; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • De Oliveira MW; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Al-Doujaily H; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Sandberg M; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Viré E; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Cunningham TJ; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Asante EA; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Brandner S; Division of Neuropathology and Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.
  • Collinge J; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Mead S; Medical Research Council Prion Unit at University College London (UCL), UCL Institute of Prion Diseases, London W1W 7FF, UK. Electronic address: s.mead@prion.ucl.ac.uk.
Neurobiol Dis ; 190: 106363, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37996040
ABSTRACT
Sporadic Creutzfeldt-Jakob disease (sCJD), the most common human prion disease, is thought to occur when the cellular prion protein (PrPC) spontaneously misfolds and assembles into prion fibrils, culminating in fatal neurodegeneration. In a genome-wide association study of sCJD, we recently identified risk variants in and around the gene STX6, with evidence to suggest a causal increase of STX6 expression in disease-relevant brain regions. STX6 encodes syntaxin-6, a SNARE protein primarily involved in early endosome to trans-Golgi network retrograde transport. Here we developed and characterised a mouse model with genetic depletion of Stx6 and investigated a causal role of Stx6 expression in mouse prion disease through a classical prion transmission study, assessing the impact of homozygous and heterozygous syntaxin-6 knockout on disease incubation periods and prion-related neuropathology. Following inoculation with RML prions, incubation periods in Stx6-/- and Stx6+/- mice differed by 12 days relative to wildtype. Similarly, in Stx6-/- mice, disease incubation periods following inoculation with ME7 prions also differed by 12 days. Histopathological analysis revealed a modest increase in astrogliosis in ME7-inoculated Stx6-/- animals and a variable effect of Stx6 expression on microglia activation, however no differences in neuronal loss, spongiform change or PrP deposition were observed at endpoint. Importantly, Stx6-/- mice are viable and fertile with no gross impairments on a range of neurological, biochemical, histological and skeletal structure tests. Our results provide some support for a pathological role of Stx6 expression in prion disease, which warrants further investigation in the context of prion disease but also other neurodegenerative diseases considering syntaxin-6 appears to have pleiotropic risk effects in progressive supranuclear palsy and Alzheimer's disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Príons / Síndrome de Creutzfeldt-Jakob / Doenças Priônicas Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Príons / Síndrome de Creutzfeldt-Jakob / Doenças Priônicas Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article